-
CMS Coverage for PHP Telehealth Services Set to End After May 11
As the COVID-19 Public Health Emergency (PHE) draws to a close at the end of Thursday, May 11, the Centers for Medicare & Medicaid Services (CMS) has shared with NABH and other stakeholders the agency’s plans to end telehealth coverage…
-
DEA Extends COVID-19 Telehealth Flexibilities for Prescription of Controlled Medications for Now
The U.S. Drug Enforcement Administration (DEA) on Wednesday said it will extend its COVID-19 telemedicine flexibilities for prescription of controlled medications as the agency works to determine how to move forward in a way that gives Americans access to needed…
-
NABH Education & Research Foundation Webpage Now Features Grants & Funding Opportunities
The NABH Research and Education Foundation has updated its webpage with a section devoted to potential funding resources and opportunities for behavioral healthcare organizations and their employees. To access the Foundation’s webpage, visit NABH’s homepage and locate the “NABH Foundation”…
-
FDA Approves First Over-the-Counter Naloxone Spray
The U.S. Food and Drug Administration (FDA) today approved Narcan, 4 mg. naloxone hydrochloride nasal spray for over-the-counter (OTC), non-prescription use, making it the first naloxone product approved to use without a prescription. Naloxone is a medication that reverses the…